NCT00487916
- Conditions
- Infections, Malaria, Mosquito-Borne Diseases, +3 more
- Locations
-
- QIMR - CLive Berghofer Cancer Research Centre Herston, Australia
Clinical trial condition
Malaria
Explore clinical trials studying Malaria. Study availability and eligibility vary by location and protocol.
715 public trials
19 recruiting studies
Malaria trial results
NCT00772642
- Conditions
- Infections, Malaria, Malaria, Falciparum, +4 more
- Locations
-
- Malaria Research and Training Center Bamako, Mali
Completed
Experimental Vaccine for Malaria
NCT00114010
- Conditions
- Infections, Malaria, Mosquito-Borne Diseases, +3 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Completed
Malaria Vaccine in Children in Mali
NCT00341250
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +19 more
- Locations
-
- Bancoumana Clinical Trial Center Bankoumana, Mali
- Doneguebougou Malaria Vaccine Center Donéguébougou, Mali
Completed
Phase I Study of Safety and Immunogenicity of AMA1-C1Alhydrogel + CPG 7909 Vaccine for Malaria
NCT00414336
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +19 more
- Locations
-
- Doneguebougou Malaria Vaccine Center Donéguébougou, Mali
Completed
Malaria Vaccine for Children in Mali
NCT00740090
- Conditions
- Infections, Malaria, Malaria Infection, +5 more
- Locations
-
- Malaria Research and Training Center Bamako, Mali
NCT00471666
- Conditions
- Coinfection, Filariasis, Helminthiasis, +9 more
- Locations
-
- Faculty of Medicine, Pharmacy and Odonto-Stomatology (FMPOS) Bamako, Mali
NCT02600975
- Conditions
- Infections, Malaria, Mosquito-Borne Diseases, +3 more
- Locations
-
- CCVTM, University of Oxford Oxford, United Kingdom
- NIHR Wellcome Trust Clinical Research Facility Southampton, United Kingdom
Completed
Tafenoquine/Chloroquine DDI Study
NCT00871156
- Conditions
- Infections, Malaria, Mosquito-Borne Diseases, +3 more
- Locations
-
- GSK Investigational Site Buffalo, New York, United States
Completed
G6PD (Glucose-6-phosphate Dehydrogenase) Study to Evaluate Hemolysis Potential of TFQ (Tafenoquine)
NCT01205178
- Conditions
- Infections, Malaria, Mosquito-Borne Diseases, +3 more
- Locations
-
- GSK Investigational Site Bangkok, Thailand
- GSK Investigational Site Tak, Thailand